Gts Securities LLC Bio N Tech Se Call Options Transaction History

Gts Securities LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	BUY	$78.36 - $124.66 $595,536 - $947,416	7,600 Added 76.0%	17,600 $2.09 Million
Q2 2024 Aug 14, 2024	SELL	$80.36 - $102.87 $1.31 Million - $1.68 Million	-16,300 Reduced 61.98%	10,000 $803,000
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $1.77 Million - $2.24 Million	-19,900 Reduced 43.07%	26,300 $2.43 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $2.33 Million - $2.89 Million	25,600 Added 124.27%	46,200 $4.88 Million
Q3 2023 Nov 15, 2023	BUY	$98.5 - $125.08 $2.03 Million - $2.58 Million	20,600 New	20,600 $2.24 Million

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.